Novo Nordisk files for approval of diabetes drug in US and Europe
Both the US and the European applications contain documentation from an extensive clinical development program that included around 6,500 people of which approximately 4,200 received liraglutide. The program
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.